EP 0981624 A2 20000301 - $i(LEISHMANIA) ANTIGENS FOR USE IN THE THERAPY AND DIAGNOSIS OF LEISHMANIASIS
Title (en)
$i(LEISHMANIA) ANTIGENS FOR USE IN THE THERAPY AND DIAGNOSIS OF LEISHMANIASIS
Title (de)
LEISHMANIA ANTIGENE ZUR VERWENDUNG IN LEISHMANIASIS THERAPIE UND DIAGNOSE
Title (fr)
ANTIGENES $i(LEISHMANIA) UTILISES DANS LE TRAITEMENT ET LE DIAGNOSTIC DE LA LEISHMANIOSE
Publication
Application
Priority
- US 9803002 W 19980212
- US 79884197 A 19970212
- US 92060997 A 19970827
Abstract (en)
[origin: WO9835045A2] Compositions and methods for preventing, treating and detecting leishmaniasis and stimulating immune responses in patients are disclosed. The compounds provided include polypeptides that contain at least an immunogenic portion of one or more Leishmania antigens, or a variant thereof. Vaccines and pharmaceutical compositions comprising such polypeptides, or DNA molecules encoding such polypeptides, are also provided and may be used, for example, for the prevention and therapy of leishmaniasis, as well as for the detection of Leishmania infection
IPC 1-7
C12N 15/30; C07K 14/44; C12N 15/63; C12N 5/10; A61K 39/008; A61K 48/00
IPC 8 full level
C07K 14/44 (2006.01); C12N 15/30 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01)
CPC (source: EP)
C07K 14/44 (2013.01); A61K 38/00 (2013.01); A61K 39/00 (2013.01); A61K 2039/51 (2013.01); Y02A 50/30 (2018.01)
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9835045 A2 19980813; WO 9835045 A3 19981029; BR 9807332 A 20001031; EP 0981624 A2 20000301; EP 2284186 A1 20110216
DOCDB simple family (application)
US 9803002 W 19980212; BR 9807332 A 19980212; EP 10177490 A 19980212; EP 98907489 A 19980212